01616nam 2200325z- 450 991079683660332120210112135856.01-58528-581-1(CKB)4100000004827102(MiAaPQ)EBC5412768(EXLCZ)99410000000482710220180708cuuuuuuuu -u- -engBiosimilars and biologics implementation and monitoring in a healthcare setting /Steven LucioAmerican Society of Health-System Pharmacists1-58528-580-3 A new type of blockbuster : the growth of biologics -- Déjá vu or something new? : comparing the generics and biosimilars experiences -- Bugs and drugs, and yeast and mice, and Chinese hamsters -- The $250 billion pyramid : analytics in biosimilarity determination -- The global biosimilars experience -- The American biosimilar experience : red, white, and possibly interchangeable -- Biosimilar clinical trial requirements -- Immunogenicity and pharmacovigilance in the biosimilar era -- The patent dance and the exclusivity shuffle -- Defining biosimilar value and other impossible tasks -- Biosimilar formulary management strategies.Biosimilars and Biologics Biosimilar PharmaceuticalsDrug CompoundingDrug MonitoringBiosimilar PharmaceuticalsDrug CompoundingDrug Monitoring615.1/9Lucio Steven1501857BOOK9910796836603321Biosimilars and biologics3729190UNINA